Items Tagged ‘Campostar’

May 12th, 2016

Avastin®/Camptosar® Improves Outcomes Compared with Temodar® in Glioblastoma

By

The treatment combination consisting of Avastin (bevacizumab) plus Camptosar (irinotecan) improves time to cancer progression compared to treatment with Temodar (temozolomide) in patients with newly diagnosed glioblastoma. These results were recently published in the Journal of Clinical Oncology. Glioblastoma is an extremely aggressive form of brain cancer. Standard therapy includes surgery to remove as much […]

View full entry

Tags: avastin, bevacizumab, Brain Cancer, Campostar, glioblastoma, irinotecan, News, nonmethylated O6-methylguanine–DNA methyltransferase promotor, Temodar, temozolomide